Register now for 16 April -

Event | Do you know the value of your business? It’s time you do!

The Monthly: April 2023

04 Apr 2023 / Corporate research

Feature article:

2022 Pharma Statistics

8.7% growth – but worrying signs

An efficient reporting system has seen all the listed multinational pharmaceutical companies announcing results for 2022, which has given us the opportunity to update our industry statistics and drug database. This report provides the first snapshot of the global and US rankings of the top 20 drug companies for 2022. 2022 was characterised by 8.7% underlying growth, offset by a large forex impact (-12%), due to USD strength. Much of the growth was driven by antibody-derived drugs and vaccines for treatment and prevention of COVID-19. A worrying sign was the unusually large number of drugs that saw sales decline in the past year.

Download the full report

Request a meeting

If you'd like to be introduced to the team at , get in touch.

Request a meeting
Download the full report